BofA Securities Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $60

Moomoo News01:32 ET · Ratings

Analysts' Top Healthcare Picks: RxSight (RXST), Pacific Biosciences (PACB)

TipRanks00:40 ET · Ratings

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

GlobeNewswireJan 2 16:05 ET

RxSight, Inc.'s (NASDAQ:RXST) Stock Retreats 25% But Revenues Haven't Escaped The Attention Of Investors

Simply Wall StDec 26, 2024 05:00 ET

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT NewswiresDec 20, 2024 15:57 ET

RxSight Down Over 13%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk

Dow JonesDec 20, 2024 15:35 ET